Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1202502017 | Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
1478562017 | Antazoline phosphate+naphazoline hydrochloride 5mg/0.5mg solution | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3049491000052113 | antazolinfosfat + nafazolinhydroklorid 5 mg/0,5 mg, lösning | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
antazolinfosfat + nafazolinhydroklorid 5 mg/0,5 mg, lösning | Is a | antazolinfosfat | false | Inferred relationship | Some | ||
antazolinfosfat + nafazolinhydroklorid 5 mg/0,5 mg, lösning | Has active ingredient | Antazoline phosphate (substance) | false | Inferred relationship | Some | ||
antazolinfosfat + nafazolinhydroklorid 5 mg/0,5 mg, lösning | Is a | antazolinfosfat + nafazolinhydroklorid | false | Inferred relationship | Some | ||
antazolinfosfat + nafazolinhydroklorid 5 mg/0,5 mg, lösning | Has active ingredient | Naphazoline hydrochloride | false | Inferred relationship | Some | ||
antazolinfosfat + nafazolinhydroklorid 5 mg/0,5 mg, lösning | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
antazolinfosfat + nafazolinhydroklorid 5 mg/0,5 mg, lösning | Is a | nafazolin för oftalmiskt bruk | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set